Cargando…
Labetalol infusion for refractory hypertension causing severe hypotension and bradycardia: an issue of patient safety
Incremental doses of intravenous labetalol are safe and effective and, at times, such therapy may need to be augmented by a continuous infusion of labetalol to control severe hypertension. Continuous infusions of labetalol may exceed the recommended maximum daily dose of 300 mg on occasion. We repor...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2429901/ https://www.ncbi.nlm.nih.gov/pubmed/18505576 http://dx.doi.org/10.1186/1754-9493-2-13 |